Company
Headquarters: Lanzhou, China
Employees: 298
CN¥2.12 Billion
CNY as of July 1, 2024
US$291.5 Million
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd researches, develops, produces, and sells Chinese medicines and health food. It offers Yuanhu Zhitong dropping pills, Qiwei Wenyang capsules, Maxing Zhike capsules, Suanzaoren oil dropping pills, Xiaoshuan Tongluo tablets, Xiaoyanlidan tablets, Compound Danshen tablets, Snage films, Astragalus Angelica capsules, etc. The company was founded in 2002 and is based in Lanzhou, China.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd has the following listings and related stock indices.
Stock: SZSE: 300534 wb_incandescent